Guangdong Association Of Clinical Trials
Clinical trials sponsored by Guangdong Association Of Clinical Trials, explained in plain language.
-
New hope for tough lung cancers: quadruple therapy targets resistant tumors
Disease control Not yet recruitingThis study tests a combination of four drugs (QL1706, bevacizumab, and two chemotherapy drugs) in people with advanced non-squamous lung cancer whose tumors have specific gene changes and have stopped responding to targeted therapy. The goal is to see if this treatment can shrink…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for lung cancer patients whose immunotherapy stopped working
Disease control Not yet recruitingThis study tests a combination of two drugs, chidamide and ivonescimab, in 32 adults with advanced non-small cell lung cancer that has stopped responding to immunotherapy and has a specific protein marker (high YAP). The goal is to see if the combo can shrink tumors or delay canc…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Real-World data sought on new lung cancer drug IBI351
Knowledge-focused Not yet recruitingThis study will review medical records of 600 Chinese patients with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called KRAS G12C. All patients received the drug IBI351 between August 2024 and August 2025. Researchers will measure how many patien…
Sponsor: Guangdong Association of Clinical Trials • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC